glp 1 studies 2025 GLP-1 Impact: How GLP-1s Are Changing the Diabetes Treatment Paradigm Mapping the effectiveness and risks

On 1 July, the Centers for Medicare & Medicaid Services (CMS) will launch a pilot program that will allow some adults ages 65 and above to only pay $50 each month for a GLP-1 drug

Recent A1c results

If your personal data is processed outside the EEA, this will only take place in countries for which the European Commission has decided that they ensure an adequate level of protection, or where appropriate safeguards are in place

2022 The major difference between these agents lies in canagliflozin, which is less selective for SGLT2 over SGLT1 and is metabolized primarily in the liver (compared to kidneys), and sotagliflozin, which inhibits both SGLT1 and SGLT2